ZLAB
Zai Lab Limited
NASDAQ · Healthcare · Biotechnology · CN
$26.23
−2.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.85x
- Price / sales
- 6.55x
- Price / cash flow
- -22.08x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 5.74x
- EV / EBITDA
- -15.29x
- EV / EBIT
- -9.78x
- Market cap
- $2.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026